SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-019012
Filing Date
2017-11-13
Accepted
2017-11-13 06:33:46
Documents
71
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20170930_10q.htm 10-Q 715097
2 EXHIBIT 31.1 ex_100329.htm EX-31.1 11109
3 EXHIBIT 31.2 ex_100330.htm EX-31.2 11201
4 EXHIBIT 32.1 ex_100331.htm EX-32.1 4769
5 EXHIBIT 32.2 ex_100333.htm EX-32.2 4823
12 dffn20170930_10qimg002.jpg GRAPHIC 27368
  Complete submission text file 0001437749-17-019012.txt   4967549

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dffn-20170930.xml EX-101.INS 972195
7 XBRL TAXONOMY EXTENSION SCHEMA dffn-20170930.xsd EX-101.SCH 61190
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20170930_cal.xml EX-101.CAL 49253
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20170930_def.xml EX-101.DEF 410693
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20170930_lab.xml EX-101.LAB 344819
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20170930_pre.xml EX-101.PRE 431871
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 171192892
SIC: 2834 Pharmaceutical Preparations